Duke University School of Medicine has launched Discovery AI , an ambitious research initiative that aims to accelerate the application of artificial intelligence (AI) and machine learning to discovery science in biomedicine. These include existing core facilities in genomics and sequencing, microbiomics, proteomics, metabolomics, advanced imaging and microscopy, CryoEM, and emerging platforms for protein design and engineering. Future hires will bring expertise in cell foundation models, agentic AI, and conditional generative models, Soderling said. Singh, a full-time assistant professor, was recruited from MIT’s Computer Science AI Lab, and has created several new AI tools. He sees promise in the ability of AI to accelerate therapeutic discovery and to make protein modeling and design accessible to scientists without computational expertise.